Publications
NOSTRINbeta--a shortened NOSTRIN variant with a role in transcriptional regulation.
Wiesenthal A, Hoffmeister M, Siddique M, Kovacevic I, Oess S, Müller-Esterl W, Siehoff-Icking A.
Traffic. 2009 Jan;10(1):26-34 |
Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets. Hoffmeister M, Riha P, Neumüller O, Danielewski O, Schultess J, Smolenski AP.
J Biol Chem. 2008 Jan 25;283(4):2297-306. |
The iromycins, a new family of pyridone metabolites from Streptomyces sp. I. Structure, NOS inhibitory activity, and biosynthesis. Surup F, Wagner O, von Frieling J, Schleicher M, Oess S, Müller P, Grond S.
J Org Chem. 2007 Jul 6;72(14):5085-90 |
Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis. Mookerjee RP, Wiesenthal A, Icking A, Hodges SJ, Davies NA, Schilling K, Sen S, Williams R, Novelli M, Müller-Esterl W, Jalan R.
Gastroenterology. 2007 Jun;132(7):2533-41. |
Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. de Oliveira SK, Hoffmeister M, Gambaryan S, Müller-Esterl W, Guimaraes JA, Smolenski AP.
J Biol Chem. 2007 May 4;282(18):13656-63. |
Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN.
Schilling K, Opitz N, Wiesenthal A, Oess S, Tikkanen R, Müller-Esterl W, Icking A.
Mol Biol Cell. 2006 Sep;17(9):3870-80 |
FCH/Cdc15 domain determines distinct subcellular localization of NOSTRIN. Icking A, Schilling K, Wiesenthal A, Opitz N, Müller-Esterl W.
FEBS Lett. 2006 Jan 9;580(1):223-8. |
Subcellular targeting and trafficking of nitric oxide synthases. Oess S, Icking A, Fulton D, Govers R, Müller-Esterl W.
Biochem J. 2006 Jun 15;396(3):401-9. Review. |
NOSTRIN functions as a homotrimeric adaptor protein facilitating internalization of eNOS. Icking A, Matt S, Opitz N, Wiesenthal A, Müller-Esterl W, Schilling K.
J Cell Sci. 2005 Nov 1;118(Pt 21):5059-69. |
Cell cycle-regulated inactivation of endothelial NO synthase through NOSIP-dependent targeting to the cytoskeleton. Schleicher M, Brundin F, Gross S, Müller-Esterl W, Oess S.
Mol Cell Biol. 2005 Sep;25(18):8251-8. |
NOSIP and its interacting protein, eNOS, in the rat trachea and lung. König P, Dedio J, Oess S, Papadakis T, Fischer A, Müller-Esterl W, Kummer W.
J Histochem Cytochem. 2005 Feb;53(2):155-64. |
Nitric oxide synthase (NOS)-interacting protein interacts with neuronal NOS and regulates its distribution and activity. Dreyer J, Schleicher M, Tappe A, Schilling K, Kuner T, Kusumawidijaja G, Müller-Esterl W, Oess S, Kuner R.
J Neurosci. 2004 Nov 17;24(46):10454-65. |
To NO or not to NO: 'where?' is the question. Govers R, Oess S.
Histol Histopathol. 2004 Apr;19(2):585-605. Review. |
Spinal upregulation of the nitric oxide synthase-interacting protein NOSIP in a rat model of inflammatory pain. Dreyer J, Hirlinger D, Müller-Esterl W, Oess S, Kuner R.
Neurosci Lett. 2003 Oct 16;350(1):13-6. |
NOSTRIN: a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Zimmermann K, Opitz N, Dedio J, Renne C, Muller-Esterl W, Oess S.
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17167-72. |